MyFinsight
Home
Blog
About
Contact
Download
Download image
Short-term investments
$230,636K
Other current assets
(including 429 and 0 as of...
$20,514K
Cash and cash
equivalents
$15,116K
Total current assets
$266,266K
Other assets
$5,648K
Equity method
investment in gannet...
$3,491K
Operating lease
right-of-use assets
$2,941K
Property, plant and
equipment, net
$2,060K
Total assets
$280,406K
Total liabilities and
stockholders equity
$280,406K
Total liabilities
$190,574K
Total stockholders
equity
$89,832K
Accumulated deficit
-$3,760,286K
Operating lease
liabilities, less current...
$65,256K
Liabilities related to the
sales of future...
$63,157K
Total current
liabilities
$53,536K
Other long-term
liabilities
$8,625K
Capital in excess of par
value
$3,850,099K
Less unamortized
transaction costs
$814K
Accumulated other
comprehensive income (loss)
$17K
Common stock, 0.0001
par value...
$2K
Liabilities related to the
sales of future...
$63,971K
Accrued expenses
(including 994 and 3,403 as...
$22,271K
Operating lease
liabilities, current portion
$20,495K
Accounts payable
(including 137 and 0 as of...
$10,770K
Back
Back
Balance Sheet
source: myfinsight.com
NEKTAR THERAPEUTICS (NKTR)
NEKTAR THERAPEUTICS (NKTR)